Who backs Expedition Therapeutics?
14 investors · 1 led rounds| Investor | Type | First invested | Role |
|---|---|---|---|
| General Atlantic | Growth equity | Aug 2026 | lead |
| RA Capital Management | Asset manager | Aug 2026 | |
| Novo Holdings | Other | — | |
| Venrock | Venture capital | — | |
| Forbion | Venture capital | — | |
| Logos Capital | Hedge fund | — | |
| Vivo Capital | Venture capital | Aug 2026 | |
| Adage Capital Management | Hedge fund | — | |
| Balyasny Asset Management | Hedge fund | — | |
| Lake Bleu Capital | Hedge fund | — | |
| + 4 more investors · a free account shows the complete list | |||
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Expedition Therapeutics investors
14 investors are on record for Expedition Therapeutics, including General Atlantic, RA Capital Management, Novo Holdings and Venrock. By type, the record holds 4 hedge funds, 3 venture capital firms and 1 asset manager. 1 of them led a round. The Series B in Aug 2026 drew 13 investors.
Free account
More of Expedition Therapeutics with a free account
- ·The post-money valuation on its round
- ·The complete investor list: 14 names
- ·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 14 firms already write checks for companies like Expedition Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View